Note: Ingredients listed on restricted chemical lists
EC/CAS
247-500-7/55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<0,0015
EC/CAS
215-279-6
Name of the chemical
Calcium carbonate
Concentration
≥10
EC/CAS
220-239-6
Name of the chemical
Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one 2-Methyl-2H-isothiazol-3-one
Concentration
=100
General Information
Version
6.2
Revision date
2024-03-18
Product name
PROMASEAL -AG
1.2.1 Relevant identified uses
Professional use
supplier name
Other
Emergency telephone
+353 1 809 2566, +353 1 809 2166, +356 2545 6508, 0845 4647
Icons in SDS
Company Information
company name
Etex Building Performance GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info.at@etexgroup.com, info@promat-international.com, info@promat.it, marketinguk@promat.co.uk, fds.efbp@etexgroup.com, top@promattop.pl, info@promat.es, info@promat-see.com, office@promat.ch, promat.praha@etexgroup.com, Promat-dk@etexgroup.com, mail@promat.de, PAPL.mail@etexgroup.com, info@promatfp.ae
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Supplemental label elements
EUH208 - Contains reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247- 500-7], and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1)(55965-84-9). May produce an allergic reaction. EUH210 - Safety data sheet available on request.
Additional information
Contains a 3:1 mixture of 5-chloro-2-methyl-2H-isothiazo-3-one and 2-Methyl-2H-isothiazol- 3-one as active substance for storage protection according to Biocidal Products Regulation (EU) No 528/2012 Art. 58(3).
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
